STEPHANIE VOGEL: Open Payments
NPI 1720736119 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$65,139 in 289 payments from 17 companies in 2025. Trend: 2023 $3,448 · 2024 $42,102 · 2025 $65,139
Speaker / faculty: $49,963Travel & lodging: $10,094Food & beverage: $4,458Consulting: $625
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 82 | $38,525 |
| ABBVIE INC. | 88 | $19,676 |
| PFIZER INC. | 30 | $4,992 |
| Janssen Biotech, Inc. | 25 | $637 |
| Takeda Pharmaceuticals U.S.A., Inc. | 26 | $446 |
| Regeneron Healthcare Solutions, Inc. | 6 | $186 |
| GENZYME CORPORATION | 8 | $144 |
| Aimmune Therapeutics, Inc. | 7 | $139 |
| Organon LLC | 4 | $99 |
| Phathom Pharmaceuticals, Inc. | 3 | $72 |
Products named: OMVOH, RINVOQ, SKYRIZI, VELSIPITY, TREMFYA, ENTYVIO, DUPIXENT, XELJANZ.
Industry payments across MO — which companies pay providers there.
